In a significant development in Delaware, where the makers of Roundup are corporate domiciled, plaintiff’s counsel has initiated the first liability trial over Roundup, the controversial weedkiller. This follows their successful case in Missouri, where a jury awarded three plaintiffs who suffered non-Hodgkin lymphoma a total of $1.56 billion in damages in November. The consequences of this case could set a powerful precedent for future litigation.
Roundup has been at the center of ongoing global disputes over its possible links to certain types of cancer, particularly non-Hodgkin lymphoma. The product’s manufacturer continues to insist on its safety, despite growing legal and public opposition and rising compensation payouts.
Details of the ongoing trial in Delaware are awaited. To follow the legal proceedings closely and stay up-to-date with further developments, legal professionals can refer to the full trial coverage provided by the Delaware Law Weekly.